Literature DB >> 16030467

Cancer anorexia-cachexia syndrome: psychological effect on the patient and family.

Susan McClement1.   

Abstract

The majority of patients with advanced cancer experience weight loss, reduced appetite, fatigue, and weakness. Chronic nausea and early satiety may also occur. This constellation of symptoms is known as the cancer anorexia-cachexia syndrome. Together with cancer pain, cancer anorexia-cachexia syndrome has been identified as 1 of the 2 most frequent and devastating problems affecting individuals with advanced malignancies. Research examining the issue of cancer anorexia-cachexia syndrome has been conducted; however, such work is largely biomedical in orientation. In contrast, the psychologic dimensions of the cancer anorexia-cachexia syndrome experience from the perspective of terminally ill patients and their family members is less well explored or described. The ability to provide psychosocial support to patients and families requires that caregivers appreciate the psychologic effect of cancer anorexia and cachexia on these individuals. This article examines that effect in light of existing knowledge and discusses the clinical implications arising from this work.

Entities:  

Mesh:

Year:  2005        PMID: 16030467     DOI: 10.1097/00152192-200507000-00012

Source DB:  PubMed          Journal:  J Wound Ostomy Continence Nurs        ISSN: 1071-5754            Impact factor:   1.741


  16 in total

1.  A cross-sectional study examining the prevalence of cachexia and areas of unmet need in patients with cancer.

Authors:  Ola Magne Vagnildhaug; Trude Rakel Balstad; Sigrun Saur Almberg; Cinzia Brunelli; Anne Kari Knudsen; Stein Kaasa; Morten Thronæs; Barry Laird; Tora Skeidsvoll Solheim
Journal:  Support Care Cancer       Date:  2017-12-22       Impact factor: 3.603

Review 2.  Body image in cancer survivors: a systematic review of case-control studies.

Authors:  Vicky Lehmann; Mariët Hagedoorn; Marrit A Tuinman
Journal:  J Cancer Surviv       Date:  2014-12-02       Impact factor: 4.442

3.  Can anorexia predict patient satisfaction with quality of life in advanced cancer?

Authors:  Christopher G Lis; Digant Gupta; James F Grutsch
Journal:  Support Care Cancer       Date:  2008-04-02       Impact factor: 3.603

4.  Validation of the Head and Neck Patient Symptom Checklist as a nutrition impact symptom assessment tool for head and neck cancer patients.

Authors:  Karmen N Schmidt; Kärin Olson; Catherine Kubrak; Matthew Parliament; Sunita Ghosh
Journal:  Support Care Cancer       Date:  2012-05-16       Impact factor: 3.603

5.  Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model.

Authors:  R Northrup; K Kuroda; E Manning Duus; S Routt Barnes; L Cheatham; T Wiley; C Pietra
Journal:  Support Care Cancer       Date:  2013-04-12       Impact factor: 3.603

6.  The changing causal foundations of cancer-related symptom clustering during the final month of palliative care: a longitudinal study.

Authors:  Karin Olson; Leslie Hayduk; Marilyn Cree; Ying Cui; Hue Quan; John Hanson; Peter Lawlor; Florian Strasser
Journal:  BMC Med Res Methodol       Date:  2008-06-04       Impact factor: 4.615

Review 7.  Psychosocial, educational and communicative interventions for patients with cachexia and their family carers.

Authors:  Joanne Reid
Journal:  Curr Opin Support Palliat Care       Date:  2014-12       Impact factor: 2.302

8.  Cancer cachexia: impact, mechanisms and emerging treatments.

Authors:  Vanessa C Vaughan; Peter Martin; Paul A Lewandowski
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-10-25       Impact factor: 12.910

Review 9.  The role of dietary nutrition in stomach cancer.

Authors:  Zoran Stojcev; Konrad Matysiak; Michal Duszewski; Tomasz Banasiewicz
Journal:  Contemp Oncol (Pozn)       Date:  2013-10-07

10.  Psychosocial impact of cancer cachexia.

Authors:  Jane B Hopkinson
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-04-16       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.